Oftalmologia (Bucharest, Romania : 1990) · 2002
[Trans scleral cyclophotocoagulation with diode laser, modern method of treatment in cyclodestructive surgery].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stanca Horia Tudor
Аннотация
PURPOSE: To analyze the results in lower IOP using cyclophotocoagulaton with diode laser in a refractory glaucoma series of cases (standard protocol).
METHOD: 23 eyes from 23 subjects, watched for 6 months (preliminary results). Power 1600 mW, exposure 500 ms, wave 810 nm. The parameters who had been watched: IOP, VA, neovascularization, corneal oedema, epitelial breaks, pain and photophobia.
RESULTS: IOP had changed from 32.08 mm Hg to 20.47 mm Hg. VA had been stationary in 65.2% cases; decreased in 30.43% and increased in 4.34% cases; 43.47% subjects needed just another laser session and 13.04% needed two another interventions. Average sessions 1.69; average power 18.08 W; average applications 22.6.
CONCLUSIONS: The protocol used, repeated in need, seems to be sure and efficient in lower IOP and in ocular pain relief in refractory glaucoma cases with minimum VA.
METHOD: 23 eyes from 23 subjects, watched for 6 months (preliminary results). Power 1600 mW, exposure 500 ms, wave 810 nm. The parameters who had been watched: IOP, VA, neovascularization, corneal oedema, epitelial breaks, pain and photophobia.
RESULTS: IOP had changed from 32.08 mm Hg to 20.47 mm Hg. VA had been stationary in 65.2% cases; decreased in 30.43% and increased in 4.34% cases; 43.47% subjects needed just another laser session and 13.04% needed two another interventions. Average sessions 1.69; average power 18.08 W; average applications 22.6.
CONCLUSIONS: The protocol used, repeated in need, seems to be sure and efficient in lower IOP and in ocular pain relief in refractory glaucoma cases with minimum VA.